Josue Ramos Islas

Dr. Josue Ramos Islas

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Josue Ramos IslasJosue Ramos Islas
Josue Ramos Islas
MLManuel López-Cabanillas Lomelí
Manuel López-Cabanillas Lomelí
BGBlanca Edelia González-Martínez
Blanca Edelia González-Martínez
Israel Ricardo Ramos IslasIsrael Ricardo Ramos Islas
Israel Ricardo Ramos Islas
MLMyriam Gutiérrez López
Myriam Gutiérrez López
MHMichel Stéphane Heya
Michel Stéphane Heya
Kidney diseases represent an increasingly significant global public health challenge, with an estimated prevalence of around 10% among adults and a rising trend influenced by factors such as population aging and exposure to nephrotoxic agents. Given the limitations of conventional treatments, which often only slow disease progression and may cause adverse effects, there is growing interest in exploring alternative therapies based on natural compounds. Sansevieria trifasciata, commonly known for its ornamental use, has been widely used in traditional medicine in Mexico and other tropical regions due to its antioxidant, anti-inflammatory, and regenerative properties. Recently, its phytochemical profile has drawn scientific attention, particularly due to its high content of hydroxylated aromatic compounds such as flavonoids, terpenes, and phenolic acids, which may offer protective effects on kidney function. For this review, searches were conducted in specialized databases such as PubMed, Scopus, and Google Scholar, as well as platforms like ChEMBL and SWISS, selecting articles published between 2008 and 2025. This work aims to compile and critically analyze the available scientific literature on the nephroprotective potential of the phytochemicals found in S. trifasciata, and includes a preliminary exploration of their possible mechanisms of action using pharmacokinetic and pharmacodynamic prediction tools.

25 July 2025 in Brazilian Journal of Health Review
Verified
Journal Article
Closed access
ERElaine Elizabeth Valle Rios
Elaine Elizabeth Valle Rios
MMMelissa Pérez Muñiz
Melissa Pérez Muñiz
Josue Ramos IslasJosue Ramos Islas
Josue Ramos Islas
DHDavid Gilberto García Hernandez
David Gilberto García Hernandez
EOEduardo Alejandro Diaz Ochoa
Eduardo Alejandro Diaz Ochoa
MHMichel Stéphane Heya
Michel Stéphane Heya
Los trastornos de la conducta alimentaria (TCA) representan un creciente problema de salud pública, especialmente entre adolescentes y adultos jóvenes. Su detección oportuna es esencial, ya que muchas personas presentan síntomas sin recibir diagnóstico ni tratamiento. En México, se estima que uno de cada cuatro adolescentes presenta algún grado de TCA, y en estados como Nuevo León la incidencia ha aumentado considerablemente. Diversas instituciones coinciden en que estos trastornos están relacionados con múltiples factores de riesgo, como hábitos alimenticios desordenados, presiones estéticas, emociones negativas y antecedentes familiares o personales. Este estudio tiene como finalidad identificar dichos factores de riesgo en una muestra representativa de estudiantes del estado de Nuevo León, México. Se observó una alta frecuencia de conductas alimentarias preocupantes, especialmente entre mujeres, además de síntomas físicos, emocionales y antecedentes personales compatibles con TCA. La mayoría no contaba con diagnóstico médico, pese a presentar señales de alerta. Lo anterior permite concluir que muchos jóvenes podrían estar en riesgo sin saberlo, lo que refuerza la importancia de una detección temprana y un enfoque integral de prevención.

19 June 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
Josue Ramos IslasJosue Ramos Islas
Josue Ramos Islas
SGSalas Rogelio García
Salas Rogelio García
CGCarolina Salazar Guerrero
Carolina Salazar Guerrero
JGJimena Estefania Gaspar-Rivera
Jimena Estefania Gaspar-Rivera
MSMirna E. Santos
Mirna E. Santos
Josep TurJosep Tur
Josep Tur
Background: Obesity is a multifactorial metabolic disorder characterized by chronic low-grade inflammation, oxidative stress, mitochondrial dysfunction, lipotoxicity, dysregulated adipogenesis, and alterations in the gut microbiota, which collectively contribute to insulin resistance and cardiometabolic complications. In this context, dietary patterns rich in bioactive compounds have gained relevance as potential strategies to modulate these interconnected pathways. Objective: To assess the potential of the Milpa Diet (a sustainable, plant-dominant Mesoamerican eating pattern centered on the ancient three sisters’ polyculture of maize, beans, and squash, along with chili) as a culturally relevant, multi-axis functional dietary pattern, and to evaluate the molecular mechanisms underlying obesity-associated with metabolic dysfunction. Methods: A scoping review of preclinical and clinical studies was conducted using Medline via PubMed, Scopus, and Web of Science databases. The ChEMBL database was also used to identify chemical structures. The search focused on evidence related to inflammation, oxidative stress, adipogenesis, lipotoxicity, mitochondrial function, and gut microbiota modulation in the context of the main foods of the Milpa Diet, including maize, legumes, chili peppers, nopal, and quelites. Studies were selected based on peer-review status and their relevance to molecular, metabolic, and functional outcomes. Results: The current evidence shows that the core components of the Milpa Diet provide dietary fiber and a broad range of bioactive compounds, such as flavonoids, carotenoids, capsaicinoids, phenolic acids, pigments, and vitamins, which exhibit antioxidant and anti-inflammatory effects. These compounds have been associated with modulation of adipogenesis and lipotoxicity, preservation of mitochondrial function, and favorable regulation of gut microbiota composition and activity, collectively influencing metabolic pathways relevant to obesity. Conclusions: Overall, mechanistic and emerging clinical evidence suggests that the Milpa Diet represents a multi-axis nutritional strategy with potential to mitigate obesity-related metabolic dysfunction through coordinated effects on inflammation, oxidative stress, adipogenesis, lipotoxicity, mitochondrial function, and gut microbiota regulation. Although comprehensive clinical trials evaluating this dietary pattern as an integrated intervention remain limited, current evidence supports its relevance for future translational research, public health strategies, and the development of sustainable dietary models aimed at improving metabolic health.